nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC1—Irinotecan—colon cancer	0.148	0.211	CbGbCtD
Ofloxacin—ABCC1—Vincristine—colon cancer	0.13	0.185	CbGbCtD
Ofloxacin—ABCC2—Irinotecan—colon cancer	0.11	0.156	CbGbCtD
Ofloxacin—ABCC2—Vincristine—colon cancer	0.096	0.137	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—colon cancer	0.0785	0.112	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—colon cancer	0.0581	0.0828	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—colon cancer	0.0425	0.0606	CbGbCtD
Ofloxacin—CYP1A2—Fluorouracil—colon cancer	0.0393	0.0559	CbGbCtD
Ofloxacin—ABCC2—bile—colon cancer	0.00584	0.316	CbGeAlD
Ofloxacin—TOP2A—Topotecan—Irinotecan—colon cancer	0.00241	0.404	CbGdCrCtD
Ofloxacin—TOP2A—Vindesine—Vincristine—colon cancer	0.00172	0.289	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vincristine—colon cancer	0.00109	0.182	CbGdCrCtD
Ofloxacin—SLC22A4—renal system—colon cancer	0.000911	0.0492	CbGeAlD
Ofloxacin—TOP2A—bone marrow—colon cancer	0.00086	0.0465	CbGeAlD
Ofloxacin—TOP2A—vagina—colon cancer	0.000824	0.0446	CbGeAlD
Ofloxacin—ABCC2—renal system—colon cancer	0.000778	0.0421	CbGeAlD
Ofloxacin—TOP2A—Vinblastine—Vincristine—colon cancer	0.000748	0.125	CbGdCrCtD
Ofloxacin—SLC22A4—digestive system—colon cancer	0.000747	0.0404	CbGeAlD
Ofloxacin—Sparfloxacin—ABCB1—colon cancer	0.000699	0.42	CrCbGaD
Ofloxacin—SLC22A4—bone marrow—colon cancer	0.000689	0.0372	CbGeAlD
Ofloxacin—SLC22A4—vagina—colon cancer	0.00066	0.0357	CbGeAlD
Ofloxacin—ABCC2—digestive system—colon cancer	0.000638	0.0345	CbGeAlD
Ofloxacin—SLC22A5—renal system—colon cancer	0.000603	0.0326	CbGeAlD
Ofloxacin—CYP1A2—renal system—colon cancer	0.000546	0.0295	CbGeAlD
Ofloxacin—TOP2A—lymph node—colon cancer	0.000533	0.0288	CbGeAlD
Ofloxacin—ABCC1—vagina—colon cancer	0.000496	0.0268	CbGeAlD
Ofloxacin—SLC22A5—digestive system—colon cancer	0.000494	0.0267	CbGeAlD
Ofloxacin—Levofloxacin—ABCB1—colon cancer	0.000492	0.295	CrCbGaD
Ofloxacin—ABCC2—liver—colon cancer	0.000475	0.0257	CbGeAlD
Ofloxacin—Ciprofloxacin—ABCB1—colon cancer	0.000475	0.285	CrCbGaD
Ofloxacin—CYP1A2—digestive system—colon cancer	0.000448	0.0242	CbGeAlD
Ofloxacin—SLC22A5—vagina—colon cancer	0.000436	0.0236	CbGeAlD
Ofloxacin—SLC22A4—lymph node—colon cancer	0.000427	0.0231	CbGeAlD
Ofloxacin—ABCC1—liver—colon cancer	0.000419	0.0226	CbGeAlD
Ofloxacin—SLC22A5—liver—colon cancer	0.000368	0.0199	CbGeAlD
Ofloxacin—ABCC2—lymph node—colon cancer	0.000364	0.0197	CbGeAlD
Ofloxacin—CYP1A2—liver—colon cancer	0.000334	0.018	CbGeAlD
Ofloxacin—ABCC1—lymph node—colon cancer	0.000321	0.0174	CbGeAlD
Ofloxacin—SLC22A5—lymph node—colon cancer	0.000282	0.0153	CbGeAlD
Ofloxacin—Anaphylactic shock—Fluorouracil—colon cancer	0.000221	0.000814	CcSEcCtD
Ofloxacin—Oedema—Fluorouracil—colon cancer	0.000221	0.000814	CcSEcCtD
Ofloxacin—Anorexia—Irinotecan—colon cancer	0.00022	0.00081	CcSEcCtD
Ofloxacin—Ataxia—Methotrexate—colon cancer	0.00022	0.00081	CcSEcCtD
Ofloxacin—Infection—Fluorouracil—colon cancer	0.00022	0.000809	CcSEcCtD
Ofloxacin—Haemoglobin—Capecitabine—colon cancer	0.000219	0.000805	CcSEcCtD
Ofloxacin—Rhinitis—Capecitabine—colon cancer	0.000218	0.000803	CcSEcCtD
Ofloxacin—Hepatitis—Capecitabine—colon cancer	0.000218	0.000801	CcSEcCtD
Ofloxacin—Haemorrhage—Capecitabine—colon cancer	0.000218	0.000801	CcSEcCtD
Ofloxacin—Nervous system disorder—Fluorouracil—colon cancer	0.000217	0.000798	CcSEcCtD
Ofloxacin—Thrombocytopenia—Fluorouracil—colon cancer	0.000217	0.000797	CcSEcCtD
Ofloxacin—Hypoaesthesia—Capecitabine—colon cancer	0.000216	0.000797	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000216	0.000795	CcSEcCtD
Ofloxacin—Pharyngitis—Capecitabine—colon cancer	0.000216	0.000795	CcSEcCtD
Ofloxacin—Tachycardia—Fluorouracil—colon cancer	0.000216	0.000794	CcSEcCtD
Ofloxacin—Hypotension—Irinotecan—colon cancer	0.000216	0.000794	CcSEcCtD
Ofloxacin—Urinary tract disorder—Capecitabine—colon cancer	0.000215	0.000791	CcSEcCtD
Ofloxacin—Insomnia—Vincristine—colon cancer	0.000214	0.000789	CcSEcCtD
Ofloxacin—Oedema peripheral—Capecitabine—colon cancer	0.000214	0.000789	CcSEcCtD
Ofloxacin—Connective tissue disorder—Capecitabine—colon cancer	0.000214	0.000787	CcSEcCtD
Ofloxacin—Urethral disorder—Capecitabine—colon cancer	0.000213	0.000785	CcSEcCtD
Ofloxacin—Paraesthesia—Vincristine—colon cancer	0.000213	0.000784	CcSEcCtD
Ofloxacin—Breast disorder—Methotrexate—colon cancer	0.000212	0.000778	CcSEcCtD
Ofloxacin—Anorexia—Fluorouracil—colon cancer	0.000211	0.000776	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000211	0.000776	CcSEcCtD
Ofloxacin—Visual impairment—Capecitabine—colon cancer	0.00021	0.000771	CcSEcCtD
Ofloxacin—Insomnia—Irinotecan—colon cancer	0.000209	0.000769	CcSEcCtD
Ofloxacin—Paraesthesia—Irinotecan—colon cancer	0.000207	0.000763	CcSEcCtD
Ofloxacin—Hypotension—Fluorouracil—colon cancer	0.000207	0.000761	CcSEcCtD
Ofloxacin—Decreased appetite—Vincristine—colon cancer	0.000206	0.000759	CcSEcCtD
Ofloxacin—Dyspnoea—Irinotecan—colon cancer	0.000206	0.000758	CcSEcCtD
Ofloxacin—Erythema multiforme—Capecitabine—colon cancer	0.000206	0.000757	CcSEcCtD
Ofloxacin—Somnolence—Irinotecan—colon cancer	0.000205	0.000755	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Vincristine—colon cancer	0.000205	0.000753	CcSEcCtD
Ofloxacin—Fatigue—Vincristine—colon cancer	0.000204	0.000752	CcSEcCtD
Ofloxacin—Eye disorder—Capecitabine—colon cancer	0.000203	0.000748	CcSEcCtD
Ofloxacin—Dyspepsia—Irinotecan—colon cancer	0.000203	0.000748	CcSEcCtD
Ofloxacin—Tinnitus—Capecitabine—colon cancer	0.000203	0.000746	CcSEcCtD
Ofloxacin—Constipation—Vincristine—colon cancer	0.000203	0.000746	CcSEcCtD
Ofloxacin—Pain—Vincristine—colon cancer	0.000203	0.000746	CcSEcCtD
Ofloxacin—Asthma—Methotrexate—colon cancer	0.000202	0.000745	CcSEcCtD
Ofloxacin—Cardiac disorder—Capecitabine—colon cancer	0.000202	0.000743	CcSEcCtD
Ofloxacin—Flushing—Capecitabine—colon cancer	0.000202	0.000743	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000202	0.000742	CcSEcCtD
Ofloxacin—Decreased appetite—Irinotecan—colon cancer	0.000201	0.000739	CcSEcCtD
Ofloxacin—Eosinophilia—Methotrexate—colon cancer	0.0002	0.000737	CcSEcCtD
Ofloxacin—Insomnia—Fluorouracil—colon cancer	0.0002	0.000736	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000199	0.000734	CcSEcCtD
Ofloxacin—Fatigue—Irinotecan—colon cancer	0.000199	0.000733	CcSEcCtD
Ofloxacin—Paraesthesia—Fluorouracil—colon cancer	0.000199	0.000731	CcSEcCtD
Ofloxacin—Pancreatitis—Methotrexate—colon cancer	0.000198	0.00073	CcSEcCtD
Ofloxacin—Pain—Irinotecan—colon cancer	0.000197	0.000727	CcSEcCtD
Ofloxacin—Constipation—Irinotecan—colon cancer	0.000197	0.000727	CcSEcCtD
Ofloxacin—Angiopathy—Capecitabine—colon cancer	0.000197	0.000726	CcSEcCtD
Ofloxacin—Dyspnoea—Fluorouracil—colon cancer	0.000197	0.000726	CcSEcCtD
Ofloxacin—Somnolence—Fluorouracil—colon cancer	0.000197	0.000724	CcSEcCtD
Ofloxacin—Immune system disorder—Capecitabine—colon cancer	0.000196	0.000723	CcSEcCtD
Ofloxacin—Mediastinal disorder—Capecitabine—colon cancer	0.000196	0.000721	CcSEcCtD
Ofloxacin—Chills—Capecitabine—colon cancer	0.000195	0.000718	CcSEcCtD
Ofloxacin—Dyspepsia—Fluorouracil—colon cancer	0.000195	0.000716	CcSEcCtD
Ofloxacin—Arrhythmia—Capecitabine—colon cancer	0.000194	0.000715	CcSEcCtD
Ofloxacin—Abdominal discomfort—Methotrexate—colon cancer	0.000194	0.000714	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Vincristine—colon cancer	0.000194	0.000714	CcSEcCtD
Ofloxacin—Decreased appetite—Fluorouracil—colon cancer	0.000192	0.000708	CcSEcCtD
Ofloxacin—Alopecia—Capecitabine—colon cancer	0.000192	0.000707	CcSEcCtD
Ofloxacin—Pancytopenia—Methotrexate—colon cancer	0.000192	0.000707	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000191	0.000703	CcSEcCtD
Ofloxacin—Mental disorder—Capecitabine—colon cancer	0.000191	0.000701	CcSEcCtD
Ofloxacin—Feeling abnormal—Irinotecan—colon cancer	0.00019	0.0007	CcSEcCtD
Ofloxacin—Malnutrition—Capecitabine—colon cancer	0.000189	0.000697	CcSEcCtD
Ofloxacin—Erythema—Capecitabine—colon cancer	0.000189	0.000697	CcSEcCtD
Ofloxacin—Dysuria—Methotrexate—colon cancer	0.000189	0.000696	CcSEcCtD
Ofloxacin—Neutropenia—Methotrexate—colon cancer	0.000189	0.000696	CcSEcCtD
Ofloxacin—Pain—Fluorouracil—colon cancer	0.000189	0.000696	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Irinotecan—colon cancer	0.000189	0.000695	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000188	0.000692	CcSEcCtD
Ofloxacin—Abdominal pain—Vincristine—colon cancer	0.000187	0.00069	CcSEcCtD
Ofloxacin—Body temperature increased—Vincristine—colon cancer	0.000187	0.00069	CcSEcCtD
Ofloxacin—Flatulence—Capecitabine—colon cancer	0.000187	0.000687	CcSEcCtD
Ofloxacin—Erectile dysfunction—Methotrexate—colon cancer	0.000186	0.000686	CcSEcCtD
Ofloxacin—Dysgeusia—Capecitabine—colon cancer	0.000185	0.000682	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Methotrexate—colon cancer	0.000185	0.00068	CcSEcCtD
Ofloxacin—Back pain—Capecitabine—colon cancer	0.000183	0.000674	CcSEcCtD
Ofloxacin—Body temperature increased—Irinotecan—colon cancer	0.000183	0.000672	CcSEcCtD
Ofloxacin—Abdominal pain—Irinotecan—colon cancer	0.000183	0.000672	CcSEcCtD
Ofloxacin—Feeling abnormal—Fluorouracil—colon cancer	0.000182	0.000671	CcSEcCtD
Ofloxacin—Muscle spasms—Capecitabine—colon cancer	0.000182	0.00067	CcSEcCtD
Ofloxacin—Pneumonia—Methotrexate—colon cancer	0.000181	0.000668	CcSEcCtD
Ofloxacin—Infestation—Methotrexate—colon cancer	0.00018	0.000664	CcSEcCtD
Ofloxacin—Infestation NOS—Methotrexate—colon cancer	0.00018	0.000664	CcSEcCtD
Ofloxacin—Drowsiness—Methotrexate—colon cancer	0.00018	0.000664	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000179	0.000658	CcSEcCtD
Ofloxacin—Vision blurred—Capecitabine—colon cancer	0.000178	0.000657	CcSEcCtD
Ofloxacin—Tremor—Capecitabine—colon cancer	0.000177	0.000653	CcSEcCtD
Ofloxacin—Renal failure—Methotrexate—colon cancer	0.000177	0.000653	CcSEcCtD
Ofloxacin—Stomatitis—Methotrexate—colon cancer	0.000176	0.000647	CcSEcCtD
Ofloxacin—Ill-defined disorder—Capecitabine—colon cancer	0.000176	0.000647	CcSEcCtD
Ofloxacin—Urticaria—Fluorouracil—colon cancer	0.000176	0.000647	CcSEcCtD
Ofloxacin—Conjunctivitis—Methotrexate—colon cancer	0.000175	0.000645	CcSEcCtD
Ofloxacin—Anaemia—Capecitabine—colon cancer	0.000175	0.000644	CcSEcCtD
Ofloxacin—Body temperature increased—Fluorouracil—colon cancer	0.000175	0.000643	CcSEcCtD
Ofloxacin—Hypersensitivity—Vincristine—colon cancer	0.000175	0.000643	CcSEcCtD
Ofloxacin—Haematuria—Methotrexate—colon cancer	0.000172	0.000633	CcSEcCtD
Ofloxacin—Malaise—Capecitabine—colon cancer	0.000171	0.000628	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Methotrexate—colon cancer	0.000171	0.000628	CcSEcCtD
Ofloxacin—Epistaxis—Methotrexate—colon cancer	0.00017	0.000626	CcSEcCtD
Ofloxacin—Vertigo—Capecitabine—colon cancer	0.00017	0.000626	CcSEcCtD
Ofloxacin—Hypersensitivity—Irinotecan—colon cancer	0.00017	0.000626	CcSEcCtD
Ofloxacin—Asthenia—Vincristine—colon cancer	0.00017	0.000626	CcSEcCtD
Ofloxacin—Syncope—Capecitabine—colon cancer	0.00017	0.000625	CcSEcCtD
Ofloxacin—Leukopenia—Capecitabine—colon cancer	0.00017	0.000624	CcSEcCtD
Ofloxacin—Agranulocytosis—Methotrexate—colon cancer	0.000168	0.00062	CcSEcCtD
Ofloxacin—Palpitations—Capecitabine—colon cancer	0.000167	0.000616	CcSEcCtD
Ofloxacin—Loss of consciousness—Capecitabine—colon cancer	0.000166	0.000613	CcSEcCtD
Ofloxacin—Asthenia—Irinotecan—colon cancer	0.000166	0.00061	CcSEcCtD
Ofloxacin—Cough—Capecitabine—colon cancer	0.000165	0.000608	CcSEcCtD
Ofloxacin—Hypertension—Capecitabine—colon cancer	0.000163	0.000602	CcSEcCtD
Ofloxacin—Hypersensitivity—Fluorouracil—colon cancer	0.000163	0.0006	CcSEcCtD
Ofloxacin—Haemoglobin—Methotrexate—colon cancer	0.000163	0.000599	CcSEcCtD
Ofloxacin—Diarrhoea—Vincristine—colon cancer	0.000162	0.000597	CcSEcCtD
Ofloxacin—Hepatitis—Methotrexate—colon cancer	0.000162	0.000596	CcSEcCtD
Ofloxacin—Haemorrhage—Methotrexate—colon cancer	0.000162	0.000596	CcSEcCtD
Ofloxacin—Myalgia—Capecitabine—colon cancer	0.000161	0.000593	CcSEcCtD
Ofloxacin—Arthralgia—Capecitabine—colon cancer	0.000161	0.000593	CcSEcCtD
Ofloxacin—Chest pain—Capecitabine—colon cancer	0.000161	0.000593	CcSEcCtD
Ofloxacin—Pharyngitis—Methotrexate—colon cancer	0.000161	0.000591	CcSEcCtD
Ofloxacin—Anxiety—Capecitabine—colon cancer	0.000161	0.000591	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00016	0.000589	CcSEcCtD
Ofloxacin—Urinary tract disorder—Methotrexate—colon cancer	0.00016	0.000589	CcSEcCtD
Ofloxacin—Discomfort—Capecitabine—colon cancer	0.000159	0.000586	CcSEcCtD
Ofloxacin—Urethral disorder—Methotrexate—colon cancer	0.000159	0.000584	CcSEcCtD
Ofloxacin—Diarrhoea—Irinotecan—colon cancer	0.000158	0.000581	CcSEcCtD
Ofloxacin—Dry mouth—Capecitabine—colon cancer	0.000158	0.00058	CcSEcCtD
Ofloxacin—Dizziness—Vincristine—colon cancer	0.000157	0.000577	CcSEcCtD
Ofloxacin—Pruritus—Fluorouracil—colon cancer	0.000156	0.000576	CcSEcCtD
Ofloxacin—Visual impairment—Methotrexate—colon cancer	0.000156	0.000574	CcSEcCtD
Ofloxacin—Confusional state—Capecitabine—colon cancer	0.000156	0.000573	CcSEcCtD
Ofloxacin—Oedema—Capecitabine—colon cancer	0.000155	0.000569	CcSEcCtD
Ofloxacin—Infection—Capecitabine—colon cancer	0.000154	0.000565	CcSEcCtD
Ofloxacin—Erythema multiforme—Methotrexate—colon cancer	0.000153	0.000563	CcSEcCtD
Ofloxacin—Dizziness—Irinotecan—colon cancer	0.000153	0.000562	CcSEcCtD
Ofloxacin—Shock—Capecitabine—colon cancer	0.000152	0.00056	CcSEcCtD
Ofloxacin—Nervous system disorder—Capecitabine—colon cancer	0.000152	0.000558	CcSEcCtD
Ofloxacin—Eye disorder—Methotrexate—colon cancer	0.000151	0.000557	CcSEcCtD
Ofloxacin—Diarrhoea—Fluorouracil—colon cancer	0.000151	0.000557	CcSEcCtD
Ofloxacin—Thrombocytopenia—Capecitabine—colon cancer	0.000151	0.000557	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—colon cancer	0.000151	0.000556	CcSEcCtD
Ofloxacin—Tachycardia—Capecitabine—colon cancer	0.000151	0.000555	CcSEcCtD
Ofloxacin—Vomiting—Vincristine—colon cancer	0.000151	0.000555	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—colon cancer	0.00015	0.000553	CcSEcCtD
Ofloxacin—Skin disorder—Capecitabine—colon cancer	0.00015	0.000552	CcSEcCtD
Ofloxacin—Rash—Vincristine—colon cancer	0.00015	0.00055	CcSEcCtD
Ofloxacin—Hyperhidrosis—Capecitabine—colon cancer	0.000149	0.00055	CcSEcCtD
Ofloxacin—Dermatitis—Vincristine—colon cancer	0.000149	0.00055	CcSEcCtD
Ofloxacin—Headache—Vincristine—colon cancer	0.000149	0.000547	CcSEcCtD
Ofloxacin—Anorexia—Capecitabine—colon cancer	0.000147	0.000542	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—colon cancer	0.000147	0.000541	CcSEcCtD
Ofloxacin—Vomiting—Irinotecan—colon cancer	0.000147	0.00054	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—colon cancer	0.000146	0.000538	CcSEcCtD
Ofloxacin—Dizziness—Fluorouracil—colon cancer	0.000146	0.000538	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—colon cancer	0.000146	0.000537	CcSEcCtD
Ofloxacin—Rash—Irinotecan—colon cancer	0.000146	0.000536	CcSEcCtD
Ofloxacin—Dermatitis—Irinotecan—colon cancer	0.000145	0.000535	CcSEcCtD
Ofloxacin—Chills—Methotrexate—colon cancer	0.000145	0.000535	CcSEcCtD
Ofloxacin—Headache—Irinotecan—colon cancer	0.000145	0.000532	CcSEcCtD
Ofloxacin—Hypotension—Capecitabine—colon cancer	0.000144	0.000531	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—colon cancer	0.000143	0.000527	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—colon cancer	0.000142	0.000522	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—colon cancer	0.000141	0.000519	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—colon cancer	0.000141	0.000519	CcSEcCtD
Ofloxacin—Nausea—Vincristine—colon cancer	0.000141	0.000518	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000141	0.000518	CcSEcCtD
Ofloxacin—Vomiting—Fluorouracil—colon cancer	0.000141	0.000517	CcSEcCtD
Ofloxacin—Insomnia—Capecitabine—colon cancer	0.00014	0.000514	CcSEcCtD
Ofloxacin—Rash—Fluorouracil—colon cancer	0.000139	0.000513	CcSEcCtD
Ofloxacin—Dermatitis—Fluorouracil—colon cancer	0.000139	0.000513	CcSEcCtD
Ofloxacin—Paraesthesia—Capecitabine—colon cancer	0.000139	0.000511	CcSEcCtD
Ofloxacin—Headache—Fluorouracil—colon cancer	0.000139	0.00051	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—colon cancer	0.000138	0.000508	CcSEcCtD
Ofloxacin—Dyspnoea—Capecitabine—colon cancer	0.000138	0.000507	CcSEcCtD
Ofloxacin—Nausea—Irinotecan—colon cancer	0.000137	0.000505	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—colon cancer	0.000136	0.000502	CcSEcCtD
Ofloxacin—Dyspepsia—Capecitabine—colon cancer	0.000136	0.000501	CcSEcCtD
Ofloxacin—Decreased appetite—Capecitabine—colon cancer	0.000134	0.000494	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000133	0.000491	CcSEcCtD
Ofloxacin—Fatigue—Capecitabine—colon cancer	0.000133	0.00049	CcSEcCtD
Ofloxacin—Vision blurred—Methotrexate—colon cancer	0.000133	0.000489	CcSEcCtD
Ofloxacin—Pain—Capecitabine—colon cancer	0.000132	0.000486	CcSEcCtD
Ofloxacin—Constipation—Capecitabine—colon cancer	0.000132	0.000486	CcSEcCtD
Ofloxacin—Nausea—Fluorouracil—colon cancer	0.000131	0.000483	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—colon cancer	0.000131	0.000481	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—colon cancer	0.00013	0.000479	CcSEcCtD
Ofloxacin—Feeling abnormal—Capecitabine—colon cancer	0.000127	0.000469	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—colon cancer	0.000127	0.000468	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—colon cancer	0.000127	0.000466	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Capecitabine—colon cancer	0.000126	0.000465	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—colon cancer	0.000126	0.000464	CcSEcCtD
Ofloxacin—Cough—Methotrexate—colon cancer	0.000123	0.000453	CcSEcCtD
Ofloxacin—Urticaria—Capecitabine—colon cancer	0.000123	0.000452	CcSEcCtD
Ofloxacin—Abdominal pain—Capecitabine—colon cancer	0.000122	0.00045	CcSEcCtD
Ofloxacin—Body temperature increased—Capecitabine—colon cancer	0.000122	0.00045	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—colon cancer	0.00012	0.000442	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—colon cancer	0.00012	0.000442	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—colon cancer	0.00012	0.000442	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000119	0.000439	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—colon cancer	0.000119	0.000436	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—colon cancer	0.000116	0.000427	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—colon cancer	0.000115	0.000423	CcSEcCtD
Ofloxacin—Infection—Methotrexate—colon cancer	0.000114	0.000421	CcSEcCtD
Ofloxacin—Hypersensitivity—Capecitabine—colon cancer	0.000114	0.000419	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—colon cancer	0.000113	0.000415	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—colon cancer	0.000113	0.000415	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—colon cancer	0.000112	0.000411	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—colon cancer	0.000111	0.000409	CcSEcCtD
Ofloxacin—Asthenia—Capecitabine—colon cancer	0.000111	0.000408	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—colon cancer	0.00011	0.000404	CcSEcCtD
Ofloxacin—Pruritus—Capecitabine—colon cancer	0.000109	0.000402	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—colon cancer	0.000108	0.000396	CcSEcCtD
Ofloxacin—Diarrhoea—Capecitabine—colon cancer	0.000106	0.000389	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000105	0.000386	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—colon cancer	0.000104	0.000383	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—colon cancer	0.000103	0.00038	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—colon cancer	0.000103	0.000377	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—colon cancer	0.000102	0.000376	CcSEcCtD
Ofloxacin—Dizziness—Capecitabine—colon cancer	0.000102	0.000376	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—colon cancer	0.000101	0.000373	CcSEcCtD
Ofloxacin—Decreased appetite—Methotrexate—colon cancer	0.0001	0.000368	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—colon cancer	9.93e-05	0.000366	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—colon cancer	9.92e-05	0.000365	CcSEcCtD
Ofloxacin—Pain—Methotrexate—colon cancer	9.84e-05	0.000362	CcSEcCtD
Ofloxacin—Vomiting—Capecitabine—colon cancer	9.83e-05	0.000362	CcSEcCtD
Ofloxacin—Rash—Capecitabine—colon cancer	9.74e-05	0.000359	CcSEcCtD
Ofloxacin—Dermatitis—Capecitabine—colon cancer	9.74e-05	0.000358	CcSEcCtD
Ofloxacin—Headache—Capecitabine—colon cancer	9.68e-05	0.000356	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—colon cancer	9.48e-05	0.000349	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—colon cancer	9.41e-05	0.000346	CcSEcCtD
Ofloxacin—Nausea—Capecitabine—colon cancer	9.18e-05	0.000338	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—colon cancer	9.14e-05	0.000336	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—colon cancer	9.1e-05	0.000335	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—colon cancer	9.1e-05	0.000335	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—colon cancer	8.48e-05	0.000312	CcSEcCtD
Ofloxacin—Asthenia—Methotrexate—colon cancer	8.25e-05	0.000304	CcSEcCtD
Ofloxacin—Pruritus—Methotrexate—colon cancer	8.14e-05	0.0003	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—colon cancer	7.87e-05	0.00029	CcSEcCtD
Ofloxacin—Dizziness—Methotrexate—colon cancer	7.61e-05	0.00028	CcSEcCtD
Ofloxacin—Vomiting—Methotrexate—colon cancer	7.32e-05	0.000269	CcSEcCtD
Ofloxacin—Rash—Methotrexate—colon cancer	7.25e-05	0.000267	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—colon cancer	7.25e-05	0.000267	CcSEcCtD
Ofloxacin—Headache—Methotrexate—colon cancer	7.21e-05	0.000265	CcSEcCtD
Ofloxacin—Nausea—Methotrexate—colon cancer	6.83e-05	0.000251	CcSEcCtD
